• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Surgical options for normalizing neuroadaptation in patients

Digital EditionOphthalmology Times: April 2022
Volume 47
Issue 4

Technical details, communication style key to presbyopia-correcting IOL journey.

Special to Ophthalmology Times®

Today’s presbyopia-correcting IOLs, such as the PanOptix Trifocal (Alcon) and TECNIS Synergy (Johnson & Johnson Vision), incorporate very sophisticated optical technologies that can provide patients with an unsurpassed range of vision. These implants, combined with excellent biometry and the greater predictability of modern IOL formulas, have led to very high levels of patient satisfaction in my practice. I believe we are truly in a golden age of presbyopic vision correction.

However, we must expect there to be a period during which the eyes and brain adapt to these sophisticated optics postoperatively. In most cases, neuroadaptation takes the form of gradually decreasing nighttime dysphotopsias or gradually improving clarity of vision. In my experience, neuroadaptation to presbyopia-correcting IOLs is nothing like the challenges that patients experience in adapting to monovision, or even to multifocal contact lenses.

Patients can typically drive and use their phones from day 1. I find that good patient selection—considering both ocular anatomy and patient personality—and clear communication with patients about what to expect postoperatively are essential for success.

Ocular anatomy often predicts who will face challenges

Preoperative testing to determine candidacy for lens options is very important. Patients with unusual topography, greater amounts of higher-order aberrations, or unusually large pupils may experience more nighttime dysphotopsias and should be counseled carefully if a premium lens is offered.

It’s also important to understand how preoperative phakic lens status affects postoperative impressions. Younger patients seeking refractive lens exchange or those with very mild cataracts may have never been challenged with quality-of-vision problems and will tend to have high expectations of matching their preoperative clarity. On the other hand, someone with significant cataract has already adapted to glare and contrast loss, which is likely to be much worse than anything they will experience with an IOL.

Patients know themselves best

For me, it is fundamentally important that a patient have a strong desire to be spectacle independent. That will motivate them to persist and tolerate any inconveniences during the immediate postoperative process. If the surgeon has to talk someone into a presbyopia-correcting IOL, that is a recipe for potential disappointment.

I also ask patients directly about their personality traits: Are you meticulous or picky? Do you flow through vacations calmly or tend to tense up when you’re out of your element? Do you transition well or tend to get stressed by change?

In my experience, patients aren’t offended by this type of questioning. Rather, they appreciate the chance to express their persona to someone who is trying to make the best recommendation for them.

The younger the patient, the healthier the crystalline lens, and the more demanding the personality, then the more preoperative counseling will be required. I don’t necessarily avoid these patients, but I am direct and specific with them. I tell them they will see more glare and halos and that these will lessen over time but may not go away entirely. After showing them images of dysphotopsias, I ask whether they think such symptoms would bother them. If so, we may look at another solution that may not provide the same range of vision but has a lower chance of dysphotopsias.

Adapting to TECNIS Synergy

We have observed that patients sometimes find that it takes time to fully appreciate crisp quality of vision across their full range with the Synergy lens. At no point have I had a patient tell me they can’t function at any one distance, but they may notice that vision improves from near to intermediate to far. I don’t see this as a problem because in the end, we are seeing spectacular results that are better than ever before (Table 1).

A golfer I recently treated is a perfect example of this. After bilateral TECNIS Synergy implantation, he told me he could drive his golf cart around and see his scorecard with no problem.

When he teed off, he could see the ball initially but had a little trouble tracking it in motion after 100 yd or so. Sunglasses in bright sunlight helped him in the short-term and within a few months after surgery, he had no complaints and was ecstatic about the visual performance of the lens.

Although I aim for plano with TECNIS Synergy, I almost always err toward the first plus in the dominant eye and the first minus in the nondominant eye if I have the choice. In most cases, this strategy provides a nice full range of focus, but it may not be appropriate in every eye. For example, if the cornea is flatter centrally, that eye may need more power, so I’ll err toward the first minus, regardless of ocular dominance.

Physician communication is key

Although preoperative evaluation is certainly a team effort in our practice, I believe it is important for the implant recommendation to come directly from the physician rather than from a counselor. My goal is that after a deliberate and intentional process to select the best technology for them, patients feel understood and can relax and embrace the surgeon’s recommendation.

I try to communicate in a way that is sincere and reality based, projecting confidence and competence. I tell patients that their vision will continue to get sharper—and they will become more and more enthusiastic about their vision—as the brain gets used to the new optics.

Sunglasses or tinted lenses, brimonidine at night, or dry eye therapies may help during the neuroadaptation period, or at least help the patient feel they are participating in the healing process.

Being honest about potential night vision symptoms or delays because of neuroadaptation doesn’t scare patients away or dissuade them from making premium choices. It simply makes their journey with today’s wonderful presbyopia-correcting implants a better one.

Dain B. Brooks, MD
E: dbrooks@brookseyemd.com
Brooks is in private practice at Brooks Eye Associates in Plano, Texas. He has no financial relationships to disclose related to this article.
Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.